Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,61,205.60
1,51,630.12
1,49,948.76
1,40,251.93
1,22,252.98
1,10,723.36
99,380.59
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,61,205.60
1,51,630.12
1,49,948.76
1,40,251.93
1,22,252.98
1,10,723.36
99,380.59
Raw Material Cost
1,49,505.36
1,40,593.11
1,38,600.84
1,30,057.48
1,13,106.33
1,01,393.04
91,245.67
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1,072.17
1,332.87
1,397.05
1,308.71
1,231.16
1,132.32
1,340.15
Selling and Distribution Expenses
7,899.55
6,776.96
6,909.64
6,421.38
5,772.90
5,386.98
4,727.75
Other Expenses
-95.59
-119.99
-122.19
-114.59
-105.03
-101.26
-126.89
Total Expenditure (Excl Depreciation)
1,57,521.15
1,47,503.05
1,45,685.67
1,36,641.67
1,19,060.12
1,06,899.72
96,044.72
Operating Profit (PBDIT) excl Other Income
3684.5
4127.099999999999
4263.1
3610.2999999999997
3192.9
3823.6000000000004
3335.8999999999996
Other Income
758.97
1,120.45
412.06
530.94
194.89
616.97
369.93
Operating Profit (PBDIT)
4,970.19
5,864.83
5,190.89
4,706.01
3,914.31
4,847.35
4,112.84
Interest
1,072.17
1,332.87
1,397.05
1,308.71
1,231.16
1,132.32
1,340.15
Exceptional Items
95.83
-99.68
-41.56
10.00
1,250.09
1,077.39
2.06
Gross Profit (PBDT)
11,700.24
11,037.01
11,347.92
10,194.45
9,146.65
9,330.32
8,134.92
Depreciation
896.18
906.51
816.46
782.55
703.55
556.63
536.73
Profit Before Tax
3,097.67
3,525.76
2,935.83
2,624.75
3,229.69
4,235.79
2,238.02
Tax
880.23
851.03
701.20
552.55
754.88
948.94
535.97
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,254.86
2,507.39
2,174.04
2,084.96
2,448.33
3,075.05
1,726.55
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,254.86
2,507.39
2,174.04
2,084.96
2,448.33
3,075.05
1,726.55
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
154.72
279.05
115.62
200.57
160.05
310.03
54.93
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,409.58
2,786.44
2,289.66
2,285.53
2,608.38
3,385.08
1,781.48
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
26,782.95
25,471.29
23,983.17
22,457.93
21,226.74
19,637.72
16,870.79
Earnings per share (EPS)
0.45
0.5
0.43
0.41
0.49
0.58
0.31
Diluted Earnings per share
0.45
0.5
0.43
0.41
0.49
0.58
0.31
Operating Profit Margin (Excl OI)
2.06%
2.53%
2.64%
2.42%
2.47%
3.32%
3.23%
Gross Profit Margin
2.48%
2.92%
2.5%
2.43%
3.22%
4.33%
2.79%
PAT Margin
1.4%
1.65%
1.45%
1.49%
2.0%
2.78%
1.74%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 6.32% vs 1.12% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -13.52% vs 21.69% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -11.24% vs -0.72% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -19.56% vs -4.60% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Jointown Pharmaceutical Group Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,61,205.60
0
1,61,205.60
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,61,205.60
0
1,61,205.60
Raw Material Cost
1,49,505.36
0
1,49,505.36
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1,072.17
0
1,072.17
Selling and Distribution Expenses
7,899.55
0
7,899.55
Other Expenses
-95.59
0.00
-95.59
Total Expenditure (Excl Depreciation)
1,57,521.15
0
1,57,521.15
Operating Profit (PBDIT) excl Other Income
3,684.45
0.00
3,684.45
Other Income
758.97
0
758.97
Operating Profit (PBDIT)
4,970.19
0
4,970.19
Interest
1,072.17
0
1,072.17
Exceptional Items
95.83
0
95.83
Gross Profit (PBDT)
11,700.24
0
11,700.24
Depreciation
896.18
0
896.18
Profit Before Tax
3,097.67
0
3,097.67
Tax
880.23
0
880.23
Provisions and contingencies
0
0
0.00
Profit After Tax
2,254.86
0
2,254.86
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,254.86
0
2,254.86
Share in Profit of Associates
0
0
0.00
Minority Interest
154.72
0
154.72
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,409.58
0
2,409.58
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
26,782.95
0
26,782.95
Earnings per share (EPS)
0.45
0
0.45
Diluted Earnings per share
0.45
0
0.45
Operating Profit Margin (Excl OI)
2.06%
0%
0.00
2.06%
Gross Profit Margin
2.48%
0%
0.00
2.48%
PAT Margin
1.40%
0%
0.00
1.40%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 16,120.56 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 6.32% vs 1.12% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 240.96 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -13.52% vs 21.69% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 421.12 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -11.24% vs -0.72% in Dec 2024
Annual - Interest
Interest 107.22 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -19.56% vs -4.60% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.06%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






